OXYBAND™ TECHNOLOGIES INC.

OxyBand Technologies Inc. develops proprietary, patented, bio medical technologies that provide therapeutic gases such as oxygen and nitric oxide for traumatic & other acute wounds, diabetic & chronic skin ulcers, eye diseases, orthopedics, regenerative medicine, antimicrobial healing & cosmetic procedures, among other applications. OxyBand has a comprehensive patent portfolio of 68 patent matters, 12 patents granted and 5 patents allowed with more patents issuing in the near term. OxyBand has developed a pipeline of healing technologies as well as a first product in the market, a unique, FDA 510 k cleared medical device, OxyBand Wound DressingTM that provides oxygen to wounds for up to 5 days. OxyBand Wound Dressing™ has been shown in three clinical trials to heal wounds faster with less pain & inflammation & without any infection compared to standard of care and placebo.

Most recently, OxyBand Wound Dressing™ was tested by the United States Army Institute for Surgical Research in a clinical trial to evaluate the efficacy of OxyBand Wound Dressing compared to standard of care. According to the published results, OxyBand Wound Dressing™ significantly accelerated healing by at least 3 days (25%) & significantly reduced pain at the wound site for larger donor site wounds without any infection compared to the standard of care. (Journal of Burn Care & Research, Supplement, March 2013).

OxyBand Wound Dressing™ is manufactured by Lighthouse for the Blind (LHB) and 3M and distributed by Lighthouse for the Blind (LHB), www.lhbindustries.com and McKesson, www.mckesson.com

OxyBand Wound Dressing™ has been shown to be safe and effective and received 510 k clearance from the FDA. OxyBand Wound Dressing™ is commercially available to order today. OxyBand Technologies is dedicated to developing, manufacturing and deploying the most effective wound and tissue healing technologies for the wounded warrior and patients everywhere.

For more information contact, information@oxyband.com